Although this study only evaluated transfer of CD45 between T cells and TNBC cells, our FFPE data suggest that TNBC cells may also acquire CD45 from macrophages, NK cells, and other types of immune cells as evidenced by expression of immune cell markers CD14, CD56, and CD68 on tumor cells. This evidence concerns the gene PTPRC and neoplasm.